Xing Xue
No. 79 Qingchun Road
Hangzhou, 310009, China
Hangzhou, 310009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Characterization of a novel composite ICE in Streptococcus agalactiae conferring resistance to macrolides [erm(TR)] and cadmium (cadA).
Journal: Frontiers in microbiology
Published: December 09, 2025
Site-Specific Nested Integration of Tn1806 into ICESa2603-Family Integrative and Conjugative Elements in Streptococcus agalactiae.
Journal: Microorganisms
Published: December 05, 2025
Preoperative prediction of early recurrence in pancreatic cancer: A novel clinical-radiomics model.
Journal: International journal of cancer
Published: May 08, 2025
Predicting tumor micronecrosis in hepatocellular carcinoma using pretreatment contrast-enhanced CT radiomics model: a multi-center study.
Journal: NPJ precision oncology
Published: April 17, 2025
Neoadjuvant Sintilimab Combined with Gemcitabine and Cisplatin for Muscle-Invasive Bladder Cancer Patients Followed by Selective Bladder Sparing Surgery: A Phase 2 Trial.
Journal: Cancer research and treatment
Published: February 24, 2025
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma.
Journal: Nature
Published: February 12, 2025
[18F]FAPI- 04 PET/CT for pathologic response assessment in pancreatic cancer patients with systemic treatment.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 28, 2025
Injectable Genetic Engineering Hydrogel for Promoting Spatial Tolerance of Transplanted Kidney in Situ.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 26, 2024
Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study.
Journal: Cancer medicine
Published: May 09, 2024
18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 21, 2023
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial.
Journal: Annals of surgical oncology
Published: November 17, 2022
Last Updated: 09/26/2026